XJZY(SZ:002332) Xin Lang Cai Jing·2025-11-27 14:52Core Viewpoint - Zhejiang Xianju Pharmaceutical Co., Ltd. announced an organizational restructuring aimed at improving governance and operational efficiency by eliminating the supervisory board and optimizing management layers [1][2]. Group 1: Organizational Restructuring - The company held its 18th meeting of the 8th Board of Directors on November 27, 2023, where the proposal for organizational restructuring was approved [1]. - The restructuring is in response to the latest revisions of the Company Law, Securities Law, and the company's articles of association, focusing on streamlining governance levels and clarifying departmental responsibilities [1][2]. - The new governance structure will consist of a three-tier system: the Shareholders' Meeting as the highest authority, the Board of Directors, and the Management Team overseeing various functional departments and business units [1][2]. Group 2: New Organizational Structure - The adjusted organizational structure includes the Shareholders' Meeting, Board of Directors, four specialized committees (Audit Committee, Compensation and Assessment Committee, Nomination Committee, and Strategy and Sustainable Development Committee), and a Board Secretary [2]. - Management will oversee functional departments such as Corporate Management and Development, Production Management, Procurement, Finance, Human Resources, Audit, Administrative Affairs, Information, and the Board Secretary's Office, along with business departments and special units [2]. - The company asserts that this restructuring aligns with regulatory requirements and its developmental needs, with the Board committing to accurate and complete information disclosure [2].